Strong CYP3A inhibitor. Increases nirogacestat exposure, which may increase risk of adverse reactions.
Source: NLP:nirogacestat
2 interactions on record
Strong CYP3A inhibitor. Increases nirogacestat exposure, which may increase risk of adverse reactions.
Source: NLP:nirogacestat
Starfruit is a moderate CYP3A inhibitor. Concomitant use increases rilzabrutinib exposure and risk of adverse reactions.
Source: NLP:rilzabrutinib